The numbers tell a story of growth. More private clinics, more prescribing clinicians, and a growing patient base accessing treatment through legal channels. But the headline figures don't tell the whole story.
The growth story
According to industry data, the number of patients accessing medical cannabis through private prescriptions has increased significantly over the past 12 months. New clinics have opened across the country, and the range of conditions being treated has expanded beyond the initial focus on severe epilepsy and multiple sclerosis.
The barriers that remain
Despite the growth, significant barriers remain. Cost is the most obvious — private prescriptions can run into hundreds of pounds per month, putting treatment out of reach for many patients who could benefit. NHS prescribing remains extremely limited, despite the law change that made cannabis-based medicines legal in 2018.
The political landscape
Calls for reform continue to grow louder. Patient advocacy groups are pushing for wider NHS access, clearer prescribing guidelines, and a more transparent regulatory framework. The Home Office's position on cannabis scheduling remains a point of contention, with many arguing that the current classification is not supported by the available evidence.
What's next
The trajectory is clear — more patients, more clinics, and more awareness. But the pace of change needs to accelerate if the UK is to realise the full potential of medical cannabis as a treatment option. The next 12 months will be crucial.
